Immunovant, Inc.
IMVTCIK 0001764013 · last filing Jul 6, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
92,188 bought / 89,721 sold
net +2,467 sh · −$2.09M
- buys
- 1
- sells
- 2
- insiders active
- 1
Filing tape
Filed Mon, Jul 6, 2026
- +2,467 sh · $2.09M
Venker Eric — Chief Executive Officer · Director
- Exercised92,188Common Stock@ $14.46→ 344,001 held
- Returned to company86,629Common Stock@ $38.14→ 257,372 held
- Sold3,092Common Stock@ $38.48→ 254,280 held
- Exercised92,188Capped Value Appreciation Rights→ 1,014,062 held
Insiders on this tape
- Venker EricChief Executive Officer · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.